The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples